BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11361746)

  • 1. Itraconazole oral solution: pharmacokinetics and absorption.
    Saag M
    AIDS Patient Care STDS; 1997 Feb; 11 Suppl 1():S16-7. PubMed ID: 11361746
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral administration of itraconazole solution has superior efficacy in experimental oral and oesophageal candidiasis in mice than its intragastric administration.
    Ishibashi H; Uchida K; Nishiyama Y; Yamaguchi H; Abe S
    J Antimicrob Chemother; 2007 Feb; 59(2):317-20. PubMed ID: 17107970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing the bioavailability of itraconazole.
    Grant EM
    Conn Med; 2000 Jul; 64(7):415-7. PubMed ID: 10946480
    [No Abstract]   [Full Text] [Related]  

  • 4. Itraconazole solution for oral yeast infections.
    TreatmentUpdate; 1998 May; 10(3):2-3. PubMed ID: 11365439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiation.
    Michallet M; Persat F; Kranzhöfer N; Levron JC; Prat C; Belhabri A; Chwetzoff E; Le Moing JP; Fiere D; Piens MA
    Bone Marrow Transplant; 1998 Jun; 21(12):1239-43. PubMed ID: 9674858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European experience with oral solution and intravenous itraconazole.
    Potter M
    Oncology (Williston Park); 2001 Nov; 15(11 Suppl 9):27-32. PubMed ID: 11757848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological, pharmacokinetic, and clinical profile of itraconazole oral solution (ITRIZOLE Oral Solution 1%)].
    Otani H; Inoue K; Shiota T; Suzuki Y; Nomura S; Harada Y; Ishibashi H; Abe S; Uchida K; Yamaguchi H; Torii S
    Nihon Yakurigaku Zasshi; 2007 Jul; 130(1):69-76. PubMed ID: 17634684
    [No Abstract]   [Full Text] [Related]  

  • 8. Itraconazole oral solution: clinical review and experience.
    Kauffman CA
    AIDS Patient Care STDS; 1997 Feb; 11 Suppl 1():S18-21. PubMed ID: 11361747
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the oral pharmacokinetics of fluconazole and itraconazole in Mexicans.
    Flores-Murrieta FJ; Carrasco-Portugal Mdel C; Landa C
    Proc West Pharmacol Soc; 2008; 51():63-5. PubMed ID: 19544680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of intravascular itraconazole in the American horseshoe crab (Limulus polyphemus).
    Allender MC; Schumacher J; Milam J; George R; Cox S; Martín-Jiménez T
    J Vet Pharmacol Ther; 2008 Feb; 31(1):83-6. PubMed ID: 18177324
    [No Abstract]   [Full Text] [Related]  

  • 11. [Improvement of patient adherence by mixing oral itraconazole solution with a beverage (orange juice)].
    Adachi Y; Sumikuma T; Kagami R; Nishio A; Akasaka K; Tsunemine H; Kodaka T; Hiramatsu Y; Tada H
    Rinsho Ketsueki; 2010 May; 51(5):315-9. PubMed ID: 20534951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of itraconazole solution used as prophylaxis for febrile neutropenia.
    Kanbayashi Y; Nomura K; Fujimoto Y; Shimura K; Shimizu D; Okamoto K; Matsumoto Y; Horiike S; Shimazaki C; Takagi T; Taniwaki M
    Int J Antimicrob Agents; 2008 May; 31(5):452-7. PubMed ID: 18359202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics.
    Willems L; van der Geest R; de Beule K
    J Clin Pharm Ther; 2001 Jun; 26(3):159-69. PubMed ID: 11422598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal design for model discrimination and parameter estimation for itraconazole population pharmacokinetics in cystic fibrosis patients.
    Waterhouse TH; Redmann S; Duffull SB; Eccleston JA
    J Pharmacokinet Pharmacodyn; 2005 Aug; 32(3-4):521-45. PubMed ID: 16307208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making sense of itraconazole pharmacokinetics.
    Prentice AG; Glasmacher A
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i17-i22. PubMed ID: 16120630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of itraconazole in Thai HIV-1-infected persons.
    Koks CH; Huitema AD; Kroon ED; Chuenyam T; Sparidans RW; Lange JM; Beijnen JH
    Ther Drug Monit; 2003 Apr; 25(2):229-33. PubMed ID: 12657919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isotretinoin may affect pharmacokinetics of itraconazole in the skin: Is it rational to combine both for the treatment of dermatophytosis?
    Srivastava A; Kothiwala SK
    Indian J Dermatol Venereol Leprol; 2017; 83(1):68-69. PubMed ID: 27853005
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioavailability of itraconazole from oral liquids in question.
    Villarreal JD; Erush SC
    Am J Health Syst Pharm; 1995 Aug; 52(15):1707-8. PubMed ID: 7583838
    [No Abstract]   [Full Text] [Related]  

  • 19. [Choice and use of antifungal drugs].
    Dupont B
    Rev Prat; 2001 Apr; 51(7):752-7. PubMed ID: 11387672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis.
    Wilcox CM; Darouiche RO; Laine L; Moskovitz BL; Mallegol I; Wu J
    J Infect Dis; 1997 Jul; 176(1):227-32. PubMed ID: 9207371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.